Your browser doesn't support javascript.
loading
The Human Genome Editing Race: Loosening Regulatory Standards for Commercial Advantage?
Cathomen, Toni; Schüle, Silke; Schüßler-Lenz, Martina; Abou-El-Enein, Mohamed.
Affiliation
  • Cathomen T; Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, Freiburg, Germany & Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Schüle S; Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany.
  • Schüßler-Lenz M; Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany.
  • Abou-El-Enein M; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: mohamed.abou-el-enein@charite.de.
Trends Biotechnol ; 37(2): 120-123, 2019 02.
Article in En | MEDLINE | ID: mdl-30017092
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Genome, Human / Drug Approval / Gene Editing Type of study: Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Humans Country/Region as subject: Europa Language: En Journal: Trends Biotechnol Year: 2019 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Genome, Human / Drug Approval / Gene Editing Type of study: Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Humans Country/Region as subject: Europa Language: En Journal: Trends Biotechnol Year: 2019 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido